Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Semaglutide is a proven, FDA-approved GLP-1 agonist for weight loss (1520% body weight reduction in clinical trials) Tirzepatide is a dual GIP/GLP-1 agonist showing up to 22% weight loss in trials often more potent than Semaglutide for some patients Retatrutide is an experimental triple agonist with promising early results, but is NOT FDA-approved and not yet available at Better Med Spa All three require medical supervision, lifestyle changes, and ongoing monitoring for safe, sustainable results Better Med Spa in Lincoln Park currently offers Semaglutide and Tirzepatide with physician-directed protocols, slow titration, and holistic wellness integration Quick Comparison: Semaglutide vs
Giblin et al., Diabetes Obes Metab 2026 (trial design paper) Note: Some media reports cite NCT05869903 for TRIUMPH-4
Properly formulated DSIP nasal spray is stable for several months at temperatures between 5C-15C
Should clinicians stop GLP-1 therapy if heart rate increases
US$ 29.36
US$ 23.68
US$ 27.15
US$ 24.97
US$ 20.19
US$ 20.10
-1775582746855.png&w=3840&q=75)
